KRSNAA Q2 : CONS NET PROFIT UP 2.9% AT 24.6 CR (YOY), UP 49.1% (QOQ). MIX (On 1st Look)

Revenue up 32% at ₹271 Cr (YOY), up 15.1% (QOQ); highest ever quarterly revenue. EBITDA up 19.4% at ₹71.9 Cr (YOY), up 22.3% (QOQ); margins 27% v 29% (YOY). PAT margin 9% v 12% (YOY); H1 FY27 PAT ₹41.1 Cr v ₹44.5 Cr (YOY). Retail revenue up 35% to ₹23.5 Cr; patient volumes up 45%, test volumes up 48%. Caution: PAT moderation in H1 FY27 due to upfront expenditure on Rajasthan project, benefits expected in coming quarters.

Krsnaa Diagnostics Ltd

Open attachment

← Back to feed